HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eisaku Ueta Selected Research

Squamous Cell Carcinoma of Head and Neck

11/2008Enhancement of apoptotic damage of squamous cell carcinoma cells by inhibition of the mitochondrial DNA repairing system.
5/2006Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
10/2003Apoptosis induction by interleukin-2-activated cytotoxic lymphocytes in a squamous cell carcinoma cell line and Daudi cells - involvement of reactive oxygen species-dependent cytochrome c and reactive oxygen species-independent apoptosis-inducing factors.
1/2003Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eisaku Ueta Research Topics

Disease

8Neoplasms (Cancer)
02/2009 - 01/2003
4Squamous Cell Carcinoma of Head and Neck
11/2008 - 01/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2008 - 03/2003
4Carcinoma (Carcinomatosis)
10/2006 - 10/2003
1Aspiration Pneumonia
05/2005
1Pneumonia (Pneumonitis)
05/2005
1Mouth Neoplasms (Oral Cancer)
05/2005
1Stomatitis
05/2005
1Mycoses (Diseases, Fungus)
11/2004
1Oral Candidiasis (Thrush)
11/2003

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
10/2006 - 11/2003
2Antimicrobial PeptidesIBA
11/2004 - 11/2003
2Peptides (Polypeptides)IBA
11/2004 - 11/2003
2Superoxide DismutaseIBA
08/2004 - 10/2003
2CatalaseIBA
01/2004 - 10/2003
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2003 - 10/2003
2Cytochromes c (Cytochrome c)IBA
10/2003 - 03/2003
2Caspase 3 (Caspase-3)IBA
10/2003 - 03/2003
1Fluorouracil (Carac)FDA LinkGeneric
02/2009
1Messenger RNA (mRNA)IBA
02/2009
1EnzymesIBA
02/2009
1ThymidineIBA
02/2009
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
02/2009
1Antineoplastic Agents (Antineoplastics)IBA
11/2008
1Mitochondrial DNA (mtDNA)IBA
11/2008
1Therapeutic UsesIBA
10/2006
1Tight Junction ProteinsIBA
05/2006
1Conditioned Culture MediaIBA
05/2006
1Matrix Metalloproteinases (MMPs)IBA
05/2006
1Claudin-1IBA
05/2006
1KalininIBA
05/2006
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2006
1DNA (Deoxyribonucleic Acid)IBA
05/2005
1LactoferrinIBA
11/2004
1Amphotericin B (Amphotericin)FDA LinkGeneric
11/2004
1Acetylcysteine (Siran)FDA LinkGeneric
01/2004
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2004
1AntioxidantsIBA
01/2004
1Bromodeoxyuridine (BrdU)IBA
10/2003
1thiazolyl blueIBA
10/2003
1PolyphenolsIBA
10/2003
1TeaIBA
10/2003
1Tyrosine (L-Tyrosine)FDA Link
03/2003
1CytokinesIBA
01/2003

Therapy/Procedure

3Chemoradiotherapy
02/2009 - 03/2003
3Therapeutics
10/2006 - 01/2003
2Radiotherapy
02/2009 - 10/2003
2Drug Therapy (Chemotherapy)
02/2009 - 10/2006
2Immunotherapy
10/2006 - 01/2003
1Intra-Arterial Infusions
10/2006
1Intravenous Infusions
10/2006